ZEVRA THERAPEUTICS, INC. ($ZVRA)
Filing Information
| Accession Number | 0001910132-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 2, 2026 |
| Document Date | Jan 29, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
139,699
Total Value
$40,035.91
P&L
+inf% (+$1,038,375.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 11,333 | โ | โ | 14,256 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 30, 2026 | Sale | 4,533 | $8.83 | $40,035.91 | 9,723 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Unit | Derivative | Jan 29, 2026 | Grant/Award | 37,500 | $0.00 | $0.00 | 37,500 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Jan 29, 2026 | Grant/Award | 75,000 | $0.00 | $0.00 | 75,000 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Unit | Derivative | Jan 30, 2026 | Exercise/Conversion | 11,333 | $0.00 | $0.00 | 22,667 | Direct | โ | View Details |